Clinical Trials Logo

Filter by:
NCT ID: NCT06336642 Recruiting - Dyspnea Clinical Trials

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Start date: June 11, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.

NCT ID: NCT06336616 Recruiting - Schizophrenia Clinical Trials

Getting Out of the House: Using Behavioral Activation to Increase Community Participation

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the effectiveness of an behavioral activation intervention to increase meaningful activity and community participation for people with serious mental illness. The overall objective of this study is to increase engagement in meaningful activities and community participation. The objectives of the project are as follows: 1. To determine if the intervention leads to increases the frequency and variety of activities. 2. To determine if the intervention leads to increases in community mobility. 3. To determine which demographic and environmental factors and mechanisms of action impact the effectiveness of the intervention. 4. To determine if the the intervention leads to an improvement in overall well-being (e.g., improved quality of life). Participants will be asked to attend a 2-hour weekly online session for 10 weeks and then a 1-hour online monthly session for a 3 month maintenance period. For data collection, participants will also be asked to: 1. Complete three, approximately 1-hour interviews at baseline, after the 10 week intervention, and again at the end of the maintenance period; 2. Carry a mobile phone with a global positioning system app to track their movements outside their home for 2 weeks at a time, at three separate times (e.g., baseline, after the intervention, and at the end of the maintenance period); and 3. Complete a 15 minute weekly interviews for 26 weeks about their daily activities and participation. The study will enroll 52 participants split into 4 cohorts of 13. The study will use a multiple baseline design and, as such, all participants will receive the intervention and there is no control group.

NCT ID: NCT06336447 Recruiting - Pain, Chronic Clinical Trials

VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain

Start date: January 12, 2024
Phase: N/A
Study type: Interventional

This study will examine the impact of virtual reality used in conjunction with sedation compared to sedation alone in patients undergoing watervcooled genicular nerve ablations for chronic knee pain. The goals of the study is to determine the relative efficacy of virtual reality as a distraction modality when used as an adjuvant to procedural sedation compared to sedation alone for procedure related pain. To assess procedural satisfaction, and 1-month pain and functional outcomes.To explore whether virtual reality and lower procedure-related pain scores affect 1-month outcomes. And finally to determine whether demographic and clinical characteristics are associated with outcome measures.

NCT ID: NCT06336382 Recruiting - Clinical trials for Late Onset Schizophrenia

Tau Biomarkers in Late-onset Psychosis (LOP)

Start date: February 16, 2024
Phase:
Study type: Observational

Hallucinations or delusions that occur for the first time in older people with no acute medical problems or mood symptoms may be related to impending dementia. This study aims to confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing.

NCT ID: NCT06336356 Recruiting - Clinical trials for Uncontrolled Hypertension

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

Start date: June 10, 2024
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to assess the serum free cortisol response after ACTH stimulation test at baseline and at Week 8 in participants with uncontrolled hypertension.

NCT ID: NCT06336343 Recruiting - Plaque Psoriasis Clinical Trials

Bimekizumab in Plaque Psoriasis

Start date: March 2024
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to evaluate the effectiveness and safety of bimekizumab in individuals with moderate-to-severe psoriasis who have failed similar therapies. Bimekizumab improves psoriasis by suppressing a type of substance found in bodies called interleukins (specifically, interleukins 17a and 17F), which are known to increase inflammation. This study will look at the effectiveness of bimekizumab in psoriasis patients that have failed previous therapies that target interleukin IL-17A or 23.

NCT ID: NCT06336304 Recruiting - Clinical trials for Urinary Incontinence

NXT Post-Market Clinical Follow-up

Start date: June 18, 2024
Phase:
Study type: Observational

NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation to Confirm Ongoing Safety and Performance in Urodynamic Patient Sub-Populations

NCT ID: NCT06336122 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

OASIS: Peer Support for T2DM in Appalachia (Peer Participant)

OASIS
Start date: February 21, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? If effective, which facets of the peer model are most effective? Peer coaches will Undergo peer coach training. Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and goal setting. Retain records of contact, topics discussed, and general notes on interactions. Researchers will compare differences in the frequency of contact, as well as how peer coaches were matched to peer participants to see if efficacy of the intervention is altered between groups.

NCT ID: NCT06336096 Recruiting - Pain Clinical Trials

A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine

Start date: March 28, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics (PK) of suzetrigine (SUZ; VX-548) and its metabolite along with its safety and tolerability, in healthy participants.

NCT ID: NCT06336018 Recruiting - Liver Diseases Clinical Trials

A Research Study on Etavopivat in Participants With and Without Liver Disease

Start date: June 4, 2024
Phase: Phase 1
Study type: Interventional

The study investigates an investigational drug called etavopivat in participants with hepatic impairments and participants with normal hepatic function (matched controls). During the study, all participants will be given a single oral dose of etavopivat. All participants will take the etavopivat orally together with water. After dosing, the study will last for 7 to 9 days.